Related references
Note: Only part of the references are listed.Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
Regis Peffault de Latour et al.
BLOOD (2015)
Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria
Peter Hillmen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Long-term efficacy and safety of eculizumab in Japanese patients with PNH: AEGIS trial
Yuzuru Kanakura et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria
Regis Peffault de Latour et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival
Richard J. Kelly et al.
BLOOD (2011)
Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria
Peter Hillmen et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Th17 immune responses contribute to the pathophysiology of aplastic anemia
Regis Peffault de Latour et al.
BLOOD (2010)
Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria
Anita Hill et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization
Anita Hill et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Imputing missing covariate values for the Cox model
Ian R. White et al.
STATISTICS IN MEDICINE (2009)
Paroxysmal nocturnal hemoglobinuria:: natural history of disease subcategories
Regis Peffault de Latour et al.
BLOOD (2008)
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
Peter Hillmen et al.
BLOOD (2007)
Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
Russell P. Rother et al.
NATURE BIOTECHNOLOGY (2007)
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
C Parker et al.
BLOOD (2005)
The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin - A novel mechanism of human disease
RP Rother et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays
VM Moyo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study
JK Lunceford et al.
STATISTICS IN MEDICINE (2004)
Marginal structural models and causal inference in epidemiology
JM Robins et al.
EPIDEMIOLOGY (2000)
Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests
JM Robins et al.
BIOMETRICS (2000)
Share Paper
